Janux Therapeutics Other Long Term Assets (Quarterly) Analysis

Janux Therapeutics, Inc. (JANX)

13.44 +0.29 (+2.21%) USD | NASDAQ | Jan 21, 14:38

View Other Long Term Assets (Quarterly) for JANX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Ionis Pharmaceuticals, Inc.	Upgrade
MannKind Corp.	Upgrade
Madrigal Pharmaceuticals, Inc.	--
Editas Medicine, Inc.	Upgrade